Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AstraZeneca

    NASDAQ: AZN · Real-Time Price · USD
    79.47
    0.30 (0.38%)
    At close: Aug 18, 2025, 1:22 PM
    0.38%
    Bid 79.47
    Market Cap 246.36B
    Revenue (ttm) 56.5B
    Net Income (ttm) 8.29B
    EPS (ttm) 2.65
    PE Ratio (ttm) 29.99
    Forward PE 14.29
    Analyst Buy
    Ask 79.49
    Volume 1,638,878
    Avg. Volume (20D) 4,580,077
    Open 79.48
    Previous Close 79.17
    Day's Range 79.26 - 79.78
    52-Week Range 61.24 - 87.68
    Beta 0.15

    About AZN

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol AZN
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for AZN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    AstraZeneca is scheduled to release its earnings on Nov 11, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 weeks ago
    +2.99%
    AstraZeneca shares are trading higher after the co... Unlock content with Pro Subscription
    2 months ago
    +2.77%
    AstraZeneca shares are trading higher after the company announced it reached a settlement regarding its antitrust class action.
    news image

    2 days ago · zacks.com

    AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

    AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.

    news image

    6 days ago · seekingalpha.com

    AstraZeneca: Great Portfolio, But Not A Great Price

    AstraZeneca PLC boasts strong 2024 results with $54B revenue and 14 blockbuster drugs, driven by robust growth in oncology and rare disease franchises. Key products like Farxiga, Tagrisso, and Ultomir...

    news image

    1 week ago · proactiveinvestors.co.uk

    Ex-dividend day weighs heavily on the FTSE this week

    Thursday is ex-dividend day in London and this week there was a heavyweight billing that knocked the FTSE 100 sideways, including companies such as AstraZeneca PLC (LSE:AZN), NatWest Group PLC (LSE:NW...

    news image

    2 weeks ago · wsj.com

    Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

    Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

    news image

    2 weeks ago · zacks.com

    JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

    JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

    news image

    2 weeks ago · zacks.com

    Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    2 weeks ago · youtube.com

    Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

    Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo...

    2 weeks ago · youtube.com

    President Trump demands drugmakers slash prices within 60 days

    CNBC's Joe Kernen reports on the latest news.

    news image

    2 weeks ago · reuters.com

    Trump pressures 17 pharma CEOs to cut US drug prices

    U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa...

    news image

    2 weeks ago · cnbc.com

    Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

    President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont...

    Add to Watchlist